Abstract. Saikosaponin-d (SSd), a triterpene saponin compound derived from Bupleurum radix, has been shown to have a cytotoxic effect on various cancer cell lines. However, its effect on prostate cancer cells has remained unexplored. The present study reports the apoptosis-inducing effect of SSd on the DU145 human prostate carcinoma cell line. Treatment with SSd inhibited DU145 cell proliferation in a concentration-dependent manner. Flow cytometric analysis showed that SSd inhibited the proliferation of DU145 cells by induction of apoptosis and cell cycle arrest at G0/G1 phase. Further mechanistic experiments demonstrated that SSd arrested the cell cycle at G0/G1 phase via upregulation of p53 and p21 and induced apoptosis by modulating B-cell lymphoma 2 family proteins, dissipation of the mitochondrial membrane potential, release of cytochrome c into the cytosol and activation of caspase-3. In conclusion the present study indicated that SSd induced apoptosis in DU145 cells by the intrinsic apoptotic pathway. Therefore, SSd may become a leading candidate drug for the therapy of prostate carcinoma.
Introduction
Saikosaponins (SSs) are triterpene saponins isolated from the root of Bupleurum falcatum L. (Umbelliferae) (1) . As all SSs have a common steroid-like structure, they were expected and also confirmed to exert a number of steroid-associated pharmacological activities (2, 3) . SSs are also regarded as the major effective components of xiao-chai-hu-tang, one of the most popular Chinese medicinal formulae that has been widely used for its various pharmacological effects, including anti-inflammatory, antioxidant and antihepatic fibrosis properties (4-6). Thus far, at least 10 types of SS have been identified, and among which saikosaponin-d (SSd) is considered to be the most active component (1, 7) . Studies have reported that SS may potently inhibit the proliferation of hepatocellular carcinoma (8) , cervical cancer (9) , lung adenocarcinoma (10), colon carcinoma (11) , breast cancer (12) and melanoma (13) cells. However, the effect of SS on human prostate cancer cell lines remains to be elucidated.
Prostate cancer is one of the most commonly diagnosed cancers among males, and is the second most common cause of cancer mortalities in developed countries (14) . With the developments in diagnosis and therapy, the mortality rate of prostate cancer has decreased significantly (15) (16) (17) (18) . Although prostate cancers are initially treatable, the androgen-insensitive or hormone-refractory recurrent cases of prostate cancer are not responsive to current therapies. Therefore, there is an urgent requirement for novel therapeutic agents.
In the present study, the anti-proliferative effects and associated mechanisms of SSd on the DU145 human prostate cancer cell line were investigated for the first time, to the best of our knowledge. UT, USA), 100 U/ml penicillin and 100 µg/ml streptomycin in a CO 2 incubator (37˚C, 5% CO 2 , 95% humidity).
MTT assay. Cell viability was determined by an MTT assay as previously described (19) . Briefly, 100 µl cell suspension (1x10 5 cells) was seeded in 96-well plates and incubated for 12 h, and then the cells were exposed to SSd (0, 1, 2.5, 5, 10, 20 or 50 μM) for 24 h. Following treatment, 20 µl MTT (5 mg/ml) was added and the cells were incubated at 37˚C for 4 h. The culture medium was removed and 150 µl DMSO was added to each well to dissolve the formazan crystals. The absorbance (570 nm) was measured using a microplate reader (Varioskan Flash; Thermo Fisher Scientific, Waltham, MA, USA). The percentage of viable cells was determined using the following formula: Cell viability (%) = (A570 treated / A570 control) x 100; and the IC 50 -values were calculated using GraphPad Prism, version 5 (GraphPad Software, Inc., La Jolla, CA, USA).
Cellular morphological changes. DU145 cells were incubated with different concentrations (3, 9 or 15 μM) of SSd for 24 h. Morphological changes of the cells were visualized under a phase contrast microscope (1x71; Olympus Corporation, Tokyo, Japan), recorded with a charge-coupled device (CCD) camera (DP72; Olympus Corporation) and analyzed using DP2-BSW software, version 2.2 (Olympus Corporation). For mouse splenocyte morphological study, the cells were analyzed by trypan blue (0.4%) staining prior to the microscopic visualization.
Flow cytometric analysis of apoptosis. Cell apoptosis was detected by flow cytometry using an Annexin V-fluorescein isothiocyanate (FITC) Apoptosis Detection kit (Beyotime Institute of Biotechnology, Shanghai, China). Briefly, DU145 cells cultured in six-well tissue culture plates were treated with different concentrations of SSd for 12 h. Following treatment, the cells were collected and washed twice with ice-chilled phosphate-buffered saline (PBS). The cell pellets were stained with Annexin V-FITC and propidium iodide (PI) according to the manufacturer's instructions. Late apoptosis was defined as Annexin V-positive/PI-positive and early apoptosis was defined as Annexin V-positive/PI-negative as determined by flow cytometry (Epics XL; Beckman Coulter, Miami, FL, USA).
Nuclear staining. Following exposure to the test compound for 12 h, the DU145 cells were harvested and washed twice with PBS. The cells were then stained with Hoechst 33258 (50 µg/ml) at 37˚C for 10 min in the dark. After the staining, the cells were washed twice with PBS and analyzed using a fluorescence microscope (1x71; Olympus Corporation) installed with a CCD camera (DP72; Olympus Corporation) and analyzed using DP2-BSW software (Olympus Corporation). Apoptotic cells were defined as cells exhibiting nuclear shrinkage and chromatin condensation.
Flow cytometric analysis of the cell cycle. DU145 cells were treated with different concentrations (3, 9 and 15 µM) of SSd for 12 h, trypsinized, washed twice with PBS and fixed in 70% ice-cold ethanol overnight. The fixed cells were rinsed twice with PBS and then stained with 50 µg/ml PI (containing 100 µg/ml RNase A) using a Cell Cycle and Apoptosis Analysis kit (Beyotime Institute of Biotechnology) according to the manufacturer's instructions. Cell cycle phase distributions of nuclear DNA were assayed using flow cytometry (Epics XL; Beckman Coulter) and CellQuest software (BD Biosciences, Franklin Lakes, NJ, USA).
Reactive oxygen species (ROS) generation detection. DU145 cells cultured in six-well tissue culture plates were treated with different concentrations of SSd. The cells were then stained with 10 µmol/l 2' ,7'-dichlorofluorescein-diacetate using a ROS Assay kit (Beyotime Institute of Biotechnology) according to the manufacturer's instructions. The cells were then collected, washed three times with PBS and assayed using flow cytometry (Epics XL; Beckman Coulter) as described previously (20) .
Mitochondrial membrane potential (MMP) determination. DU145 cells were treated with different concentrations of SSd for 12 h. The cells were trypsinized, collected in a centrifuge tube, and then stained with Rho-123 (10 µg/ml) at 37˚C for 30 min in the dark. Following staining, the cells were washed three times with PBS and assayed using flow cytometry (Epics XL; Beckman Coulter).
Western blot analysis. DU145 cells were treated with different concentrations of SSd for 12 h and then cell extracts were prepared using a Bicinchoninic Acid Protein Assay kit (Beyotime Institute of Biotechnology). The cell lysates (containing 40 µg protein) were subjected to SDS-PAGE and analyzed by western blotting using various antibodies according to standard protocols. The proteins were visualized using an Enhanced Chemiluminescence Plus kit (Millipore Corporation, Billerica, MA, USA).
Statistical analysis. All data are expressed as the mean ± standard error of the mean from at least three independent experiments. Statistical analysis was performed using Student's t-test. P<0.05 was considered to indicate a statistically significant difference. Fig. 1A ) on the proliferation of DU145 human prostate carcinoma cells were determined using an MTT assay. As shown in Fig. 1B , SSd treatment induced concentration-dependent proliferation inhibition of the DU145 cells. At 24 h, maximal inhibition was achieved with 50 µM SSd, which inhibited 80% of the DU145 cells proliferation, and the IC 50 -value of the inhibition was ~10 µM. Morphological changes of the DU145 cells treated with SSd were visualized under a phase contrast microscope, which revealed a reduced number of adherent cells accompanying an increased number of floating cells in the culture medium compared with those in the culture medium containing the untreated cells (Fig. 1C) . Furthermore, the effect of SSd on primarily cultured mouse splenocytes was investigated and trypan blue analysis indicated that SSd had little toxicity on the cells compared with the control cells (Fig. 1D) .
Results

Antiproliferative effect of SSd on DU145 human prostate carcinoma cells. The inhibitory effects of SSd (chemical structure is shown in
Effects of SSd on cell cycle distribution. Cell cycle arrest and apoptosis are major causes of cell proliferation inhibition (20) (21) (22) . To investigate the mechanisms responsible for SSd-induced inhibition of DU145 cell proliferation, the cell cycle distribution affected by SSd was measured. DU145 cells were exposed to different concentrations of SSd for 12 h and then the cell cycle distributions were determined using PI staining and flow cytometric analysis. The data indicated that SSd caused a significant accumulation of DU145 cells in G0/G1 phase compared with that of the control cells. Compared with that of the DMSO control, the proportions of cells in G0/G1 phase were increased from 51.7 to 53.3, 56.8 and 60.3% following treatment with 3, 9 and 15 µM SSd, respectively ( Fig. 2A) . To elucidate the molecular mechanism underlying the G0/G1 phase arrest induced by SSd, several key proteins involved in the G1 phase transition were investigated in DU145 cells. The cells were treated with 3, 9 and 15 µM SSd for 12 h and the expression levels of p53 and p21 proteins were analyzed by western blotting. The data showed that SSd treatment significantly increased the expression levels of p53 and p21 compared with those of the control cells (Fig. 2B) .
Effects of SSd on apoptosis induction. Subsequently, the effect of SSd on the induction of apoptosis of DU145 cells was investigated. Cell apoptosis, a type of programmed cell death, is characterized by nuclear condensation, cell shrinkage, membrane blebbing and DNA fragmentation (23), with nuclear condensation being a key characteristic (24) . Morphological changes of the cell nuclei were observed using Hoechst 33258 staining. The results revealed that treatment of DU145 cells with SSd resulted in significant levels of nuclear condensation: 3, 9 and 15 µM SSd treatment increased the percentage of cleaved nuclei from 5.13±0.84 (in the DMSO control group) to 10.01±1.71, 24.50±1.82 and 51.44±2.39%, respectively (Fig. 3A) .
To further quantify the SSd-induced apoptotic effect, the treated cells were stained with Annexin V-FITC/PI and assayed using flow cytometry. A concentration-dependent increase in the percentages of necrotic (Annexin V-positive, PI-positive) and apoptotic (Annexin V-positive, PI-negative) cells was observed. Treatment of the DU145 cells with 3, 9 and 15 µM SSd for 12 h increased the rate of apoptosis from 7.37±2.39 to 27.26±2.68, 46.43±4.43 and 75.77±3.01%, respectively, with <2% of cells being necrotic (Fig. 3B) . Notably, ~75% of the cells were apoptotic in the 15 µM SSd treatment group after 12 h, with a concomitant <10% increase in the G1 phase proportion (Fig. 2A) . G1 phase arrest may only minimally account for the antiproliferative effect of SSd observed in DU145 cells. (9) . Thus, the present study investigated the effect of SSd on the mitochondrial signaling pathway. ROS generation in DU145 cells was detected using a ROS Assay kit. As shown in Fig. 4A , following incubation with 3, 9 or 15 µM SSd for 30 min, the ROS levels in the SSd-treated group remained almost unchanged compared with those in the control group. As depolarization of the MMP is a characteristic feature of apoptosis (26, 27) , the MMP in DU145 cells was subsequently determined using Rho-123 staining and flow cytometry assay. The DU145 cells were exposed to different concentrations of SSd (3, 9 and 15 µM) for 12 h prior to Rho-123 staining. The results showed that SSd reduced the MMP in a concentration-dependent manner, from 98.15±1.84 (in the DMSO control group) to 93.17±3.91, 78.01±5.87 and 22.21±3.41%, respectively (Fig. 4B) .
Effect of SSd on cytochrome c translocation and caspase-3 activation.
Disruption of the MMP may lead to the release of cytochrome c from the intermembrane space to the cytosol, which leads to the activation of procaspase-3 (28-30). To further define the apoptotic pathway, the levels of cytosolic cytochrome c and activated caspase-3 in DU145 cells were determined. The western blotting results indicated that SSd increased the cytochrome c levels in the cytosol and induced cleavage of caspase-3 (Fig. 5) .
Effect of SSd on the expression levels of Bcl-2 and Bax.
The Bcl-2 family proteins regulate apoptosis by controlling mitochondrial membrane stability (31) . The Bcl-2 family contains anti-apoptotic, e.g. Bcl-2-associated agonist of cell death (Bad), BH3 interacting domain death agonist (Bid), Bax and Bcl-2-like 11 (apoptosis facilitator) (Bim), and pro-apoptotic, e.g. Bcl-2 and B-cell lymphoma-extra large (Bcl-xL), proteins, and the ratios of anti-apoptotic and pro-apoptotic proteins determine the fate of cells (32, 33) . The present study investigated the effect of SSd on the expression levels of Bcl-2 and Bax. As shown in Fig. 6 , SSd induced elevated levels of Bax, while it reduced levels of Bcl-2 in the DU145 cells compared with those in the control cells. 
A B d c b a Discussion
Previous studies have reported that SSd inhibited proliferation of several cancer cell lines (8) (9) (10) (11) , while its effect on human prostate cancer cells remained under investigation. The present study revealed, for the first time to the best of our knowledge, that SSd induced apoptosis in the DU145 human prostate cancer cell line. The present study also provides insights into the mechanisms involved in SSd-induced apoptosis of DU145 cells.
The results of the present study demonstrated that SSd inhibited the proliferation of DU145 cells in a concentration-dependent manner. Nuclear fragmentation and chromosomal condensation are landmarks of apoptosis (34) . The chromosomal condensation in the present study was confirmed by Hoechst 33258 staining. At the early stages of apoptosis, phosphatidyl serine (PS) is translocated from the inner face of the plasma membrane to the cell surface, while the cell membrane integrity decreases at late stages of apoptosis (35) . Apoptotic and necrotic cells are discriminated using the PS-binding dye Annexin V-FITC and the DNA-binding dye PI. The Annexin V-FITC/PI double staining results of the present study revealed that SSd treatment induced apoptosis of DU145 cells in a concentration-dependent manner and <2% of the treated cells were necrotic. Thus, the results suggested that the reduced cell viability in the MTT assay was due to apoptosis rather than necrosis.
Apoptosis is induced through two main pathways: The death receptor pathway and the intrinsic or mitochondrial pathway (29) . A previous study showed that SS induced apoptosis via mitochondria-dependent and -independent pathways (11) . As involvement of a mitochondria-mediated pathway in apoptosis is of notable value in the treatment of cancer (29), the effect of SSd on the mitochondrial apoptotic pathway was investigated in the present study. Depolarization of the MMP is a typical characteristic of apoptosis (25, 29) ; therefore, the MMP in DU145 cells was examined in the present study. The results revealed that the MMP was significantly dissipated following SSd treatment, which suggests the mitochondrial apoptotic pathway was induced by SSd.
The Bcl-2 family proteins, including anti-apoptotic (e.g. Bcl-2 and Bcl-xL) and proapoptotic (e.g. Bad, Bid, Bax and Bim) members, are key regulators in the mitochondrial apoptotic pathway (36) . A slight change in the levels of these proteins may result in apoptosis (36) . In the present study, SSd reduced the expression levels of Bcl-2 and increased the expression levels from the mitochondria, cytochrome c activates the caspase cascade through the mitochondrial transition pore (32) . The data of the present study revealed that SSd induced the release of cytochrome c and activation of caspase-3. These results further support that SSd-induced apoptosis in DU145 cells via regulation of the Bcl-2 family proteins. Cytochrome c release from mitochondria may result from overproduction of ROS (38, 39) ; thus, the effect of SSd on ROS production in DU145 cells was examined in the present study. The results showed that the ROS levels in SSd-treated DU145 cells remained unchanged compared with those in the control cells. SS compounds have long been used as antioxidants, and a previous study also confirmed the antioxidant activity of SSd in normal hepatocytes (40) . Wang et al (9) reported that SSd induced cellular ROS accumulation in several types of cell line. The reason for the differences between the results of these studies remains to be determined, but may in part be due to the different cell lines used in the studies.
Inhibition of cell proliferation is implemented by cell cycle arrest. Although the data of the present study indicated that SSd treatment caused DU145 cell cycle arrest at G1 phase, the results suggest that apoptosis was the major reason for the inhibition of cell proliferation.
p21 (Cip1/Waf1), a major transcriptional target of p53 protein, has key roles in the transition from G1 phase into S phase (41, 42) . p21 is a broad-specificity inhibitor of cyclin/cyclin-dependent kinase complexes; upregulation of p21 may lead to cell cycle arrest and inhibition of proliferation (43) . Thus, the present study examined the expression levels of p21 and p53. The data showed that SSd significantly increased the levels of these two proteins compared with those in the control cells, which further supports the conclusion that SSd induces G1 arrest in DU145 cells.
In conclusion, the present study revealed that SSd-induced mitochondrial dysfunction is the major reason for the induction of apoptotic cell death in DU145 human prostate cancer cells treated with SSd. The induction of apoptosis was associated with dissipation of the MMP, release of cytochrome c, activation of caspase-3 and modulation of Bcl-2 family proteins. G0/G1 phase arrest is a minor reason for the SSd-induced inhibition of cell proliferation; this effect was associated with upregulation of the levels of p53 and p21. Further in-depth studies are required to examine SSd-induced apoptosis and cell cycle perturbation in DU145 cells. SSd may be developed into a leading candidate drug for prostate cancer therapy. 
